The C-Type Lectin Receptor CD93 Regulates Platelet Activation and Surface Expression of the Protease Activated Receptor 4.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
30 Sep 2023
Historique:
pubmed: 6 9 2023
medline: 6 9 2023
entrez: 5 9 2023
Statut: aheadofprint

Résumé

 The C-type lectin receptor CD93 is a single pass type I transmembrane glycoprotein involved in inflammation, immunity, and angiogenesis. This study investigates the role of CD93 in platelet function. CD93 knockout (KO) mice and wild-type (WT) controls were compared in this study.  Platelet activation and aggregation were investigated by flow cytometry and light transmission aggregometry, respectively. Protein expression and phosphorylation were analyzed by immunoblotting. Subcellular localization of membrane receptors was investigated by wide-field and confocal microscopy.  The lack of CD93 in mice was not associated to any evident bleeding defect and no alterations of platelet activation were observed upon stimulation with thromboxane A2 analogue and convulxin. Conversely, platelet aggregation induced by stimulation of the thrombin receptor PAR4 was significantly reduced in the absence of CD93. This defect was associated with a significant reduction of α-granule secretion, integrin αIIbβ3 activation, and protein kinase C (PKC) stimulation. Resting WT and CD93-deficient platelets expressed comparable amounts of PAR4. However, upon stimulation with a PAR4 activating peptide, a more pronounced clearance of PAR4 from the platelet surface was observed in CD93-deficient platelets compared with WT controls. Confocal microscopy analysis revealed a massive movement of PAR4 in cytosolic compartments of activated platelets lacking CD93. Accordingly, platelet desensitization following PAR4 stimulation was more pronounced in CD93 KO platelets compared with WT controls.  These results demonstrate that CD93 supports platelet activation triggered by PAR4 stimulation and is required to stabilize the expression of the thrombin receptor on the cell surface.

Sections du résumé

BACKGROUND BACKGROUND
 The C-type lectin receptor CD93 is a single pass type I transmembrane glycoprotein involved in inflammation, immunity, and angiogenesis. This study investigates the role of CD93 in platelet function. CD93 knockout (KO) mice and wild-type (WT) controls were compared in this study.
METHODS METHODS
 Platelet activation and aggregation were investigated by flow cytometry and light transmission aggregometry, respectively. Protein expression and phosphorylation were analyzed by immunoblotting. Subcellular localization of membrane receptors was investigated by wide-field and confocal microscopy.
RESULTS RESULTS
 The lack of CD93 in mice was not associated to any evident bleeding defect and no alterations of platelet activation were observed upon stimulation with thromboxane A2 analogue and convulxin. Conversely, platelet aggregation induced by stimulation of the thrombin receptor PAR4 was significantly reduced in the absence of CD93. This defect was associated with a significant reduction of α-granule secretion, integrin αIIbβ3 activation, and protein kinase C (PKC) stimulation. Resting WT and CD93-deficient platelets expressed comparable amounts of PAR4. However, upon stimulation with a PAR4 activating peptide, a more pronounced clearance of PAR4 from the platelet surface was observed in CD93-deficient platelets compared with WT controls. Confocal microscopy analysis revealed a massive movement of PAR4 in cytosolic compartments of activated platelets lacking CD93. Accordingly, platelet desensitization following PAR4 stimulation was more pronounced in CD93 KO platelets compared with WT controls.
CONCLUSION CONCLUSIONS
 These results demonstrate that CD93 supports platelet activation triggered by PAR4 stimulation and is required to stabilize the expression of the thrombin receptor on the cell surface.

Identifiants

pubmed: 37669782
doi: 10.1055/a-2166-5841
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Ministry of Education, University and Research (MIUR)
ID : Dipartimenti di Eccellenza Program (2018-2022) -

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Silvia Maria Grazia Trivigno (SMG)

University School for Advanced Studies IUSS, Pavia, Italy.
Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Mauro Vismara (M)

Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.
Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Ilaria Canobbio (I)

Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Serena Rustichelli (S)

University School for Advanced Studies IUSS, Pavia, Italy.
Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Federico Galvagni (F)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

Maurizio Orlandini (M)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

Mauro Torti (M)

Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Gianni Francesco Guidetti (GF)

Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Classifications MeSH